Meticulous + Remedy Meds · Executive Strategic Brief

Extending the patient experience beyond the prescription.

Prepared following our recent discussion. A concise look at the strategic opportunity between Remedy Meds and Meticulous, and where it can extend Remedy's growth after the prescription is written.

Remedy Meds has already won the hardest part: getting hundreds of thousands of patients started on GLP-1 therapy. The next chapter of growth is what happens after, and it's still unclaimed.

This isn't a product pitch. It's a strategy for deepening the patient relationship exactly where the market is wide open, and where Remedy is positioned to move first.

Executive overview

The market. Remedy Meds has become a trusted leader in expanding access to GLP-1 therapy by helping patients achieve meaningful, sustainable improvements in their health through modern, patient-centered care. As GLP-1 adoption continues to accelerate, the patient journey is evolving beyond medication management alone.

The unmet need. Patients are increasingly seeking support for the broader physiological changes accompanying rapid metabolic transformation, including visible skin changes, facial volume loss, structural support, barrier disruption, recovery, sleep quality, energy, and overall confidence.

These needs do not represent a limitation of GLP-1 therapy. They represent the next opportunity to improve the patient experience.

Our platform. Meticulous was created specifically to support those biological changes. Through Meticulous, we combine advanced topical science with coordinated systemic wellness support to help patients navigate accelerated physiological transformation through one integrated platform.

Our lane. Our objective is not to compete with GLP-1 medications. Our objective is to help organizations extend the value they deliver after the prescription is written.

Why we prepared this brief

One page, five minutes. Following our recent discussion, we wanted to provide a concise overview of the opportunity we believe exists between Remedy Meds and Meticulous.

Rather than asking your team to navigate multiple pages across our website, this brief summarizes our philosophy, the science behind Meticulous, and how we believe it can complement the exceptional patient experience Remedy Meds already delivers.

Why this matters for Remedy's growth

The fastest results in the category.

Remedy Meds tells patients the truth: weight isn't a willpower problem. It's a medical one. The changes that accompany rapid weight loss deserve the same reframe. They're not a cosmetic afterthought. They're a biological reality, and the next place to compete.

300,000+
Members, plus more than 1.2 million prescriptions written. A patient base at real scale.
45 to 50 lbs
Average member loss in the first six months, twice the industry average within 90 days. The faster the transformation, the sooner its visible changes arrive.
91%
Member retention past 90 days, the same window where the physiological changes of rapid transformation concentrate.

Figures as published on remedymeds.com.

The next layer of the GLP-1 patient journey

Weight loss was only the beginning.

Early adoption centered on weight loss. Today, the conversation is expanding to encompass the complete patient experience.

Patients frequently report that while they are thrilled with the progress they see on the scale, they are often surprised by changes in facial volume, structural appearance, skin quality, recovery, energy, sleep quality, and confidence.

These experiences represent opportunities for additional support throughout the patient journey, while strengthening confidence, satisfaction, engagement, retention, and long-term value.

Skin

Visible skin changes, facial volume loss, and barrier disruption.

Structure

Structural appearance and support through rapid transformation.

Recovery

Physical recovery, energy, and sleep quality.

Confidence

The emotional experience accompanying profound physiological change.

The Meticulous Study™

Developed through direct observation.

The Meticulous Study™ is an internal observational study. We followed ten people over 90 days, all on GLP-1 medications and already noticing changes in their skin. Using standardized photography, video documentation, structured questionnaires, and regular conversations with every participant, we documented both the visible changes and the physical and emotional experience of rapid transformation.

10 people
On GLP-1 medications, and already noticing changes in their skin.
90 days
Followed weekly, from baseline through the first 90 days.
40 to 200 lbs
The range of weight loss represented across the group.

After we ran this study, patient feedback kept pointing to the same thing. People were noticing other changes, like skin, recovery, sleep, and energy, that skincare alone couldn't support. That's what led us to build an inside and outside support platform: Protocol IO™, Protocol NR™, and the Meticulous Integrated Support Platform™.

Two ways to begin
Day 0 Day 90 Patients can start on Meticulous from day one, alongside their first GLP-1 dose, or add it later, once they notice changes and come looking for support. Starting on day one means the support is already there when patients need it most. It's also the window Remedy already wins: 91% of members stay past 90 days, and being there from the start is how that experience carries into months four through twelve.
The Meticulous Integrated Support Platform™

Four technologies. One coordinated biological platform.

Remedy's promise to patients is never a gap in treatment. The platform extends it: never a gap in support. Together, these four technologies represent the first generation of the Meticulous Integrated Support Platform™.

Preparation · Topical

Longevity Hybrid Defense Serum™

Every protocol begins with preparation. The Longevity Hybrid Defense Serum™ combines advanced antioxidant technologies, four forms of Vitamin C, plant-derived stem cell technology, peptides, fulvic acid, and bioactives supported by ingredient-level research, designed to help prepare the skin through antioxidant defense, hydration, resilience, and visible vitality.

Restoration · Topical

Revolumizing Bioactive Moisturizer™

Centered on our proprietary Adipo Restore Complex™, which combines microencapsulated L-Ornithine, biomimetic peptides, postbiotic ferment lysates, phospholipid delivery systems, ceramides, and bioadaptive hydration technologies, designed to visibly improve the appearance of facial volume, support the skin's moisture barrier, and promote resilient-looking skin.

Morning · Systemic

Protocol IO™

A coordinated morning protocol formulated with ingredients studied for their role in antioxidant defense, cellular energy, recovery, and healthy aging, alongside plant-based vitamins and fulvic acid derived trace minerals. Its purpose is to help patients feel as well as they look.*

Overnight · Systemic

Protocol NR™

Protocol NR™ complements Protocol IO™, formulated to support quality sleep, a healthy stress response, overnight recovery, and morning readiness.*

Why Remedy Meds

What Remedy built. Remedy Meds has built a patient-centered approach to GLP-1 care focused on improving lives through accessible, technology-enabled healthcare. We believe the next opportunity is extending that experience beyond medication.

Where we fit. Meticulous was designed to complement organizations like Remedy Meds by supporting many of the biological changes patients experience throughout rapid physiological transformation, while strengthening engagement, confidence, and long-term relationships.

Together, we believe there is an opportunity to create a more complete patient journey that benefits patients while differentiating Remedy Meds within an increasingly competitive marketplace.

Engineered for adoption

Scientific innovation creates value only when patients can realistically participate.

Built for adoption. That philosophy led directly to the development of the Meticulous Patient Access Program™. Rather than treating affordability as an afterthought, we engineered the science, the patient experience, and the commercial model together.

The result. The result is a partnership model designed to make advanced biological support practical, scalable, and financially attainable, while helping organizations like Remedy Meds strengthen patient engagement, improve long-term retention, and extend lifetime patient value.

What this unlocks for Remedy

A more complete patient journey, together.

Together, Remedy Meds and Meticulous have the opportunity to extend the patient experience beyond medication through coordinated biological support, ongoing education, and long-term patient engagement.

Earlier patient engagement

Coordinated topical and systemic biological support

Improved confidence throughout transformation

Stronger patient retention

Increased lifetime patient value

Meaningful differentiation within the GLP-1 marketplace

A scalable patient support ecosystem designed to evolve alongside your patients

Looking ahead

The future of GLP-1 care extends beyond medication alone.

Patients increasingly expect organizations that support not only weight loss, but the broader biological changes accompanying transformation. We believe Remedy Meds is well positioned to lead that next phase of patient care.

Meticulous was engineered to support that vision by combining scientific innovation, patient accessibility, and a scalable model designed to improve the patient experience throughout the transformation journey.

We welcome the opportunity to continue our conversation and explore how Remedy Meds and Meticulous can work together to define the next generation of coordinated patient support.

The first generation helped patients begin their journey. The next will be defined by how well they support everything that comes after.

Scott Kanyok
Founder & Chief Executive Officer · Meticulous Skincare
Wesley Kanyok
Co-Founder & President · Meticulous Skincare